Downloads provided by UsageCounts
Predictive biomarkers of trabectedin represent an unmet need in advanced soft‐tissue sarcomas (STS). DNA damage repair (DDR) genes, involved in homologous recombination or nucleotide excision repair, had been previously described as biomarkers of trabectedin resistance or sensitivity, respectively. The majority of these studies only focused on specific factors (ERCC1, ERCC5, and BRCA1) and did not evaluate several other DDR‐related genes that could have a relevant role for trabectedin efficacy. In this retrospective translational study, 118 genes involved in DDR were evaluated to determine, by transcriptomics, a predictive gene signature of trabectedin efficacy. A six‐gene predictive signature of trabectedin efficacy was built in a series of 139 tumor samples from patients with advanced STS. Patients in the high‐risk gene signature group showed a significantly worse progression‐free survival compared with patients in the low‐risk group (2.1 vs 6.0 months, respectively). Differential gene expression analysis defined new potential predictive biomarkers of trabectedin sensitivity (PARP3 and CCNH) or resistance (DNAJB11 and PARP1). Our study identified a new gene signature that significantly predicts patients with higher probability to respond to treatment with trabectedin. Targeting some genes of this signature emerges as a potential strategy to enhance trabectedin efficacy.
ADN - Reparació, DNA Repair, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, Trabectedina, Estudios Retrospectivos, Dioxoles, gene signature, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de tejido conjuntivo y de tejidos blandos::sarcoma, predictive biomarkers, Predictive biomarkers, Recombinación homóloga, Tetrahydroisoquinolines, PHENOMENA AND PROCESSES::Chemical Phenomena::Biochemical Phenomena::DNA Repair, Gene signature, Humans, Sarcoma - Tractament, Antineoplastic Agents, Alkylating, RC254-282, Research Articles, Retrospective Studies, Other subheadings::Other subheadings::Other subheadings::/drug therapy, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome, Perfilación de la expresión génica, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Sarcoma, Antineoplásicos Alquilantes, Neoplasias, Tetrahidroisoquinolinas, Humanos, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Sarcoma, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento, Daño del ADN, FENÓMENOS Y PROCESOS::fenómenos químicos::fenómenos bioquímicos::reparación del ADN, Eficacia, Reparación del ADN, trabectedin, Avaluació de resultats (Assistència sanitària), Pacientes, Supervivencia sin progresión, gene signature, predictive biomarkers, trabectedin, DNA Damage, Trabectedin
ADN - Reparació, DNA Repair, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, Trabectedina, Estudios Retrospectivos, Dioxoles, gene signature, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de tejido conjuntivo y de tejidos blandos::sarcoma, predictive biomarkers, Predictive biomarkers, Recombinación homóloga, Tetrahydroisoquinolines, PHENOMENA AND PROCESSES::Chemical Phenomena::Biochemical Phenomena::DNA Repair, Gene signature, Humans, Sarcoma - Tractament, Antineoplastic Agents, Alkylating, RC254-282, Research Articles, Retrospective Studies, Other subheadings::Other subheadings::Other subheadings::/drug therapy, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome, Perfilación de la expresión génica, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Sarcoma, Antineoplásicos Alquilantes, Neoplasias, Tetrahidroisoquinolinas, Humanos, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Sarcoma, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento, Daño del ADN, FENÓMENOS Y PROCESOS::fenómenos químicos::fenómenos bioquímicos::reparación del ADN, Eficacia, Reparación del ADN, trabectedin, Avaluació de resultats (Assistència sanitària), Pacientes, Supervivencia sin progresión, gene signature, predictive biomarkers, trabectedin, DNA Damage, Trabectedin
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 13 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
| views | 69 | |
| downloads | 135 |

Views provided by UsageCounts
Downloads provided by UsageCounts